Differential expression of Vegfr-2 and its soluble form in preeclampsia - Wikidata - awgldk - TriplyDB

Differential expression of Vegfr-2 and its soluble form in preeclampsia

Differential expression of Vegfr-2 and its soluble form in preeclampsia

http://www.wikidata.org/entity/Q34201006

about

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia Design of growth factor sequestering biomaterials Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes.Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia.Identification of novel biomarkers for preeclampsia on the basis of differential expression network analysis.Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia.Serum levels of platelet endothelial cell adhesion molecule-1 (PECAM-1) and soluble vascular endothelial growth factor receptor (sVEGFR)-1 and -2 in HIV associated preeclampsia.VEGFR-1, Bcl-2, and HO-1 Ratios in Pregnant Women With Hypertension.VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae.Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy.A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.

P2860

Q26798193-1B15FB9E-B7FD-4710-833C-79B7397D512C Q34543371-9940F997-2CBC-4246-A325-29633A9D9137 Q35641606-A67095F6-6C51-4135-9F0A-823C4E6DE7D7 Q36257821-26EB62B3-0353-4127-8D10-41C3E6E339F3 Q36808609-EEF62D0A-AD38-40B0-86F6-685BF904661F Q37001083-A1C2FF3B-4EE8-4579-937A-2F888ED684A8 Q37010679-C03EDADF-A972-4410-A941-632421128CA5 Q40174475-5E481DC7-4796-4DFD-BD51-54347832ACF6 Q45945385-62673533-540D-425E-8F1B-738DC4C0129D Q47997086-17448469-C5B1-41EB-89A3-20026FFB456D Q54210006-E3149D1F-D9C0-4F91-9897-B33A10D56200 Q54361188-0F587508-AB8B-4490-9F8F-9842A476566B

P2860

Differential expression of Vegfr-2 and its soluble form in preeclampsia

http://www.wikidata.org/entity/Q34201006

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@ast

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@en

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@nl

type

label

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@ast

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@en

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@nl

prefLabel

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@ast

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@en

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@nl

P1433

Q34201006-96327C5B-0645-4CA0-A270-FF7AEC48674A

P1476

Q34201006-5E846687-7E97-40F8-BDD0-8B1B35D532D8

P2093

Q34201006-0D257709-68C3-4AAE-AC00-FBDAE17234F5

Q34201006-20A72390-77DA-4433-A07F-48631AF60914

Q34201006-4AE06A3D-8E53-4F4E-990F-6236DFC76CA1

Q34201006-6CB8A9E3-5409-4C41-8918-C0DB65456B93

Q34201006-942DE589-694A-416A-AAB3-E464458DDB8D

Q34201006-A59F3459-A342-4210-85B3-BD8744BB0E39

Q34201006-CD368481-44C1-47F8-96A0-CB95CFFF2CA0

Q34201006-CD9F0C9B-64A7-4DDF-BF30-B9FF4B677BE7

P2860

Q34201006-13A627B6-9FB8-4C62-9407-65CC0DA432FC

Q34201006-1C85F629-F223-488C-A0F8-D53EF58EEE77

Q34201006-1CC6E758-EA4B-4BC8-8A0A-57BA38D666C6

Q34201006-33E3DDE9-9254-4B4E-AD09-DEBA8D9F4AEA

Q34201006-3FE40885-9DF6-44D0-AF10-3FD1464B0D69

Q34201006-5315F766-16D6-456F-B428-98670154FAC7

Q34201006-532B2C78-D410-4901-914B-F2A862FDC59C

Q34201006-5414EAA1-8946-469C-A9E3-85E28A8F3CC8

Q34201006-5B5D594F-5EFD-4739-8280-D2415FADA464

Q34201006-5CFC7A6A-F24A-4FB5-BFEA-1CF9C7F180DE

P304

Q34201006-7CD0962B-F339-4087-B3B9-4BD298AFEE1C

P31

Q34201006-DC90532A-09E5-4598-BB6A-96A5CE89929D

P356

Q34201006-B2DAFAFE-7A9F-4F2E-9829-C5A3B66CFABD

P407

Q34201006-5438B4BA-8D35-4E4F-8483-E6A17707A531

P433

Q34201006-0790AB1C-0857-4152-9DA2-48A9F20742F2

P478

Q34201006-91BBB941-9D8B-4F55-B7B0-CBD9B9278D8B

P50

Q34201006-5BE89EFC-3C75-421E-B760-7EDF8564358D

Q34201006-AFC7D262-14B4-49CA-A97A-DFE688DD8A06

Q34201006-BA236249-58F7-49F2-A8AB-BFBEB55210FF

P577

Q34201006-2C4C51EE-3BF3-4CFC-AE49-D1196DFA735E

P5875

Q34201006-F437A0D7-DFF2-4306-92BC-00B6C76EB992

P698

Q34201006-69F04CE1-F1F1-4EF3-96C2-203460C7407B

P921

Q34201006-C92FA385-0B5B-4B1E-8CC1-48AB9C7E6297

P932

Q34201006-C08FA4A9-AA98-49E9-B412-56AB240D073B

P356

JOURNAL.PONE.0033475

P1433

P1476

Differential expression of Vegfr-2 and its soluble form in preeclampsia

@en

P2093

Capucine Coulon

http://www.w3.org/2001/XMLSchema#string

Carine Munaut

http://www.w3.org/2001/XMLSchema#string

Damien Subtil

http://www.w3.org/2001/XMLSchema#string

Frédéric Chantraine

http://www.w3.org/2001/XMLSchema#string

Frédéric Goffin

http://www.w3.org/2001/XMLSchema#string

Jeanne Le Goarant

http://www.w3.org/2001/XMLSchema#string

Sophie Lorquet

http://www.w3.org/2001/XMLSchema#string

Vassilis Tsatsaris

http://www.w3.org/2001/XMLSchema#string

P2860

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor

Soluble endoglin contributes to the pathogenesis of preeclampsia

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

VEGF receptor signalling - in control of vascular function

Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies.

Renal thrombotic microangiopathy in mice with combined deletion of endocytic recycling regulators EHD3 and EHD4.

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia.

Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

P304

e33475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0033475

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Foidart

Christel Péqueux

P577

2012-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221716470

http://www.w3.org/2001/XMLSchema#string

P698

22428059

http://www.w3.org/2001/XMLSchema#string

P921

P932

3299790

http://www.w3.org/2001/XMLSchema#string